Results 81 to 90 of about 1,148,121 (177)
Behçet Necatigil ile kısa bir söyleşi
, 1970 Taha Toros Arşivi, Dosya No: 41-Behçet ...
Necatigil, Behçet
core
Treat-to-target in Behçet syndrome
Behçet syndrome is a complex systemic immune-mediated form of vasculitis characterized by diverse clinical manifestations and a variable disease course.
Bertsias, George +10 more
core +1 more source
Mapping the Altered Landscape of TCR Repertoire in Autoimmune Diseases
Immunological Reviews, Volume 342, Issue 1, September 2026.ABSTRACT Autoimmune diseases arise from the breakdown of immune tolerance through complex interactions between genetic predisposition, environmental exposures, and adaptive immune responses. High‐throughput T‐cell receptor (TCR) repertoire sequencing has transformed our ability to characterize these responses, providing unprecedented insights into ...
Celine Albalaa +3 more
wiley +1 more source
Tubulointerstitial Nephritis With Uveitis (TINU) Syndrome: A Case Series and Review of Literature
Nephrology, Volume 31, Issue 9, September 2026.ABSTRACT Tubulointerstitial nephritis with uveitis (TINU) syndrome is a rare disorder characterised by the simultaneous or sequential occurrence of acute tubulointerstitial nephritis and uveitis, in the absence of systemic disease. Its true prevalence is likely underestimated, as renal and ocular manifestations may not appear concurrently. We conducted
Weaam Ali +5 more
wiley +1 more source
[Behçet Kemal Çağlar tarafından çıkarılan "Şadırvan" haftalık sanat mecmuasının bazı sayıları]
, 1949 Taha Toros Arşivi, Dosya No: 5-Behçet Kemal ...
core
Infliximab versus alpha interferon in the treatment of Behçet’s disease: the BIO BEHÇET’S RCT
Efficacy and Mechanism EvaluationBackground While biologic therapy, typically with infliximab or Roferon, was used for Behçet syndrome after first-line immunosuppressants, no high-quality randomised trials or predictive biomarkers were available.
Robert J Moots +8 more
doaj +1 more source
Pain Practice, Volume 26, Issue 7, September 2026.ABSTRACT Background Complex regional pain syndrome type 1 (CRPS1) is a disabling pain syndrome whose treatment remains challenging. Mesotherapy is a therapeutic method involving the injection of low doses of active substances through the skin. No studies assessed mesotherapy in CRPS1 patients.
Philippe Lafuma +12 more
wiley +1 more source
[Behçet Kemal Çağlar tarafından tarafından gönderilen mektup]
, 1935 Taha Toros Arşivi, Dosya No: 5-Behçet Kemal ...
Çağlar, Behçet Kemal
core
Neonatal Behçet’s syndrome: a case report and literature review
ReumatismoBehçet’s syndrome is a rare, chronic inflammatory disorder characterized by recurrent oral and genital ulcers, skin lesions, and eye inflammation. While most children born to mothers with Behçet’s syndrome remain asymptomatic, some newborns may develop ...
Sandra Catarina Lino Ferreira Ferraz +5 more
doaj +1 more source
Pathology International, Volume 76, Issue 9, September 2026.We report an autopsy case of VEXAS syndrome presenting with aggressive clinical course. Pathologically, the disease manifested as systemic granulocytic vasculitis affecting both arteries and veins, characterized by the presence of histiocytoid myeloid cells associated with low‐risk MDS.
Kayo Ueda +5 more
wiley +1 more source